Your browser doesn't support javascript.
loading
First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis.
Parikh, Ravi B; Feld, Emily K; Galsky, Matthew D; Adamson, Blythe Js; Cohen, Aaron B; Baxi, Shrujal S; Boursi, Shimon Ben; Christodouleas, John P; Vaughn, David J; Meropol, Neal J; Mamtani, Ronac.
Affiliation
  • Parikh RB; Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Feld EK; Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Galsky MD; Tisch Cancer Institute, Icahn School of Medicine, New York, NY 10029, USA.
  • Adamson BJ; Flatiron Health, New York, NY 10013, USA.
  • Cohen AB; Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195, USA.
  • Baxi SS; Flatiron Health, New York, NY 10013, USA.
  • Boursi SB; NYU Grossman School of Medicine, New York University, New York, NY 10016, USA.
  • Christodouleas JP; Flatiron Health, New York, NY 10013, USA.
  • Vaughn DJ; Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Meropol NJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Mamtani R; Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Future Oncol ; 16(2): 4341-4345, 2020 Jan.
Article in En | MEDLINE | ID: mdl-31840537
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Antineoplastic Combined Chemotherapy Protocols / Urologic Neoplasms / B7-H1 Antigen / Programmed Cell Death 1 Receptor Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Future Oncol Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Antineoplastic Combined Chemotherapy Protocols / Urologic Neoplasms / B7-H1 Antigen / Programmed Cell Death 1 Receptor Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Future Oncol Year: 2020 Type: Article Affiliation country: United States